ARES Trademark

Trademark Overview

On Sunday, October 16, 2022, a trademark application was filed for ARES with the United States Patent and Trademark Office. The USPTO has given the ARES trademark a serial number of 97634008. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 17, 2024. This trademark is owned by BioCut, LLC. The ARES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Engineering services, namely, engineering for the cell and gene therapy industry
ares

General Information

Serial Number97634008
Word MarkARES
Filing DateSunday, October 16, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Goods and ServicesEngineering services, namely, engineering for the cell and gene therapy industry

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 10, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioCut, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMilwaukee, WI 53223
Party NameBioCut, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMilwaukee, WI 53223

Trademark Events

Event DateEvent Description
Tuesday, January 31, 2023ASSIGNED TO EXAMINER
Wednesday, October 19, 2022NEW APPLICATION ENTERED
Monday, October 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 2, 2023NON-FINAL ACTION WRITTEN
Thursday, February 2, 2023NON-FINAL ACTION E-MAILED
Thursday, February 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 10, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, February 10, 2023EXAMINERS AMENDMENT E-MAILED
Friday, February 10, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 10, 2023EXAMINER'S AMENDMENT ENTERED
Friday, February 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 23, 2023SOU EXTENSION 1 FILED
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU EXTENSION 1 GRANTED
Monday, June 17, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

ares engineering therapy industry gene cell services namely